IL-6 has been associated with bone/joint health (or rather, bone/joint pathology) in hemophilia mice and and IL-6 signalling blockage by using IL-6 receptor antagonist may be used as an adjunct to replacement hemostasis and an approach to minimize hemophilic joint degeneration40. Here, IL6 is linked to hemophilia.